100 Per cent FDI in Pharma: Pros outweigh Cons

摘要

The last decade witnessed a tsunami of iVIerger and Acquisition (M&A) activities in the pharmaceutical sector, where a lot of overseas companies forayed into India for better and improved business opportunities. This did not go down too well with certain ministries and Non-governmental Organisations (NGOs) who perceived this as a threat to the Indian pharmaceutical industry, opining that this would raise the cost of drugs, especially generics, in addition to impacting the competitiveness due to reduced number of players.